Efficacy of Ivermectin in the treatment of COVID-19

Not Applicable

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20210901052358N4
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Laboratory confirmation of COVID-19 virus by RT-PCR or imaging findings consistent with COVID-19
Severe disease (respiratory rate more than 30 per minute, oxygen saturation less than 94%, or pulmonary infiltration more than 50% in both lungs)
Age above 18 years
Willingness to participate in this study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality. Timepoint: 5th day of hospitalization. Method of measurement: Patient medical record.;Intubation requirement. Timepoint: 5th day of hospitalization. Method of measurement: Patient medical record.

Secondary Outcome Measures

Name	Time	Method
Oxygen saturation. Timepoint: First and fifth days of hospitalization. Method of measurement: Pulse oximeter.;Respiratory rate. Timepoint: First and fifth days of hospitalization. Method of measurement: Physical examination by physician.;Serum CRP level. Timepoint: First and fifth days of hospitalization. Method of measurement: Laboratory report.;Lymphocyte count. Timepoint: First and fifth days of hospitalization. Method of measurement: Laboratory report.